BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 34815472)

  • 1. Prevalence and patient related factors associated with Extended-Spectrum Beta-Lactamase producing Escherichia coli and Klebsiella pneumoniae carriage and infection among pediatric patients in Tanzania.
    Letara N; Ngocho JS; Karami N; Msuya SE; Nyombi B; Kassam NA; Skovbjerg S; Åhren C; Philemon R; Mmbaga BT
    Sci Rep; 2021 Nov; 11(1):22759. PubMed ID: 34815472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a pediatric unit in Madagascar.
    Andriatahina T; Randrianirina F; Hariniana ER; Talarmin A; Raobijaona H; Buisson Y; Richard V
    BMC Infect Dis; 2010 Jul; 10():204. PubMed ID: 20624313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae fecal carriage among children under five years in Addis Ababa, Ethiopia.
    Tola MA; Abera NA; Gebeyehu YM; Dinku SF; Tullu KD
    PLoS One; 2021; 16(10):e0258117. PubMed ID: 34597328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and antimicrobial susceptibility of extended-spectrum beta lactamases-producing
    Mofolorunsho KC; Ocheni HO; Aminu RF; Omatola CA; Olowonibi OO
    Afr Health Sci; 2021 Jun; 21(2):505-512. PubMed ID: 34795702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology and antimicrobial susceptibility profiles of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichiacoli in China.
    Wang Y; Zhang Q; Jin Y; Jin X; Yu J; Wang K
    Braz J Microbiol; 2019 Jul; 50(3):669-675. PubMed ID: 30972583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term Carriage of Extended-Spectrum β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae in the General Population in The Netherlands.
    van Duijkeren E; Wielders CCH; Dierikx CM; van Hoek AHAM; Hengeveld P; Veenman C; Florijn A; Lotterman A; Smit LAM; van Dissel JT; Maassen CBM; de Greeff SC
    Clin Infect Dis; 2018 Apr; 66(9):1368-1376. PubMed ID: 29149242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and antimicrobial susceptibility of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a general hospital.
    Kader AA; Kumar A
    Ann Saudi Med; 2005; 25(3):239-42. PubMed ID: 16119526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy.
    Lee J; Pai H; Kim YK; Kim NH; Eun BW; Kang HJ; Park KH; Choi EH; Shin HY; Kim EC; Lee HJ; Ahn HS
    J Antimicrob Chemother; 2007 Sep; 60(3):629-37. PubMed ID: 17599919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae at admission in a Portuguese hospital.
    Aires-de-Sousa M; Lopes E; Gonçalves ML; Pereira AL; Machado E Costa A; de Lencastre H; Poirel L
    Eur J Clin Microbiol Infect Dis; 2020 Apr; 39(4):783-790. PubMed ID: 31873863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and antimicrobial resistance patterns of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated from blood cultures in an Istanbul University Hospital.
    Koksal F; Ak K; Kucukbasmaci O; Samasti M
    Chemotherapy; 2009; 55(4):293-7. PubMed ID: 19521075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EMERGENCY ROOM: AN UNRECOGNIZED SOURCE OF EXTENDED-SPECTRUM β-LACTAMASE PRODUCING ESCHERICHIA COLI AND KLEBSIELLA PNEUMONIAE.
    Pornsinchai P; Chongtrakool P; Diraphat P; Siripanichgon K; Malathum K
    Southeast Asian J Trop Med Public Health; 2015 Jan; 46(1):51-62. PubMed ID: 26513905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in spanish hospitals (GEIH-BLEE Project 2002)].
    Hernández JR; Pascual A; Cantón R; Martínez-Martínez L;
    Enferm Infecc Microbiol Clin; 2003 Feb; 21(2):77-82. PubMed ID: 12586030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Risk factors for gastrointestinal colonization by ESBL-producing Klebsiella pneumoniae and Escherichia coli in anaesthesiology and reanimation intensive care unit].
    Oğuz Mızrakçı S; Arda B; Erdem HA; Uyar M; Tünger A; Sipahi OR; Ulusoy S
    Mikrobiyol Bul; 2013 Apr; 47(2):223-9. PubMed ID: 23621722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric extended spectrum β-lactamase infection: Community-acquired infection and treatment options.
    Sethaphanich N; Santanirand P; Rattanasiri S; Techasaensiri C; Chaisavaneeyakorn S; Apiwattanakul N
    Pediatr Int; 2016 May; 58(5):338-46. PubMed ID: 26513341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin.
    Cho YH; Jung SI; Chung HS; Yu HS; Hwang EC; Kim SO; Kang TW; Kwon DD; Park K
    Int Urol Nephrol; 2015 Jul; 47(7):1059-66. PubMed ID: 26026972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal Carriage of Extended-Spectrum β-Lactamases in Healthy Humans, Poultry, and Wild Birds in León, Nicaragua-A Shared Pool of bla
    Hasan B; Laurell K; Rakib MM; Ahlstedt E; Hernandez J; Caceres M; Järhult JD
    Microb Drug Resist; 2016 Dec; 22(8):682-687. PubMed ID: 27007258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan.
    Liu HY; Lin HC; Lin YC; Yu SH; Wu WH; Lee YJ
    J Microbiol Immunol Infect; 2011 Oct; 44(5):364-8. PubMed ID: 21524974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
    Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH
    J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal carriage of extended-spectrum beta-lactamase and ampc beta-lactamase-producing enterobacteriaceae in a turkish community.
    Hazirolan G; Mumcuoglu I; Altan G; Özmen BB; Aksu N; Karahan ZC
    Niger J Clin Pract; 2018 Jan; 21(1):81-86. PubMed ID: 29411729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dramatic rise in the proportion of ESBL-producing Escherichia coli and Klebsiella pneumoniae among clinical isolates identified in Canadian hospital laboratories from 2007 to 2016.
    Denisuik AJ; Karlowsky JA; Adam HJ; Baxter MR; Lagacé-Wiens PRS; Mulvey MR; Hoban DJ; Zhanel GG;
    J Antimicrob Chemother; 2019 Aug; 74(Suppl 4):iv64-iv71. PubMed ID: 31505647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.